Bioequivalence Between Nicotine Replacement Products and Nicorette® Gum

2014-08-27 03:14:05 | BioPortfolio


Bioequivalence between oral nicotine replacement products and Nicorette® gum.


This study compares a new oral Nicotine Replacement Therapy (NRT) product containing 2 and 4 mg nicotine with Nicorette® gum 2 mg and 4 mg, after 12 hours of nicotine abstinence, with respect to nicotine pharmacokinetics, during 10 hours after start of administration. Single doses of each treatment are given once in the morning during four separate treatment visits scheduled in a crossover setting with randomized treatment sequences. The study will include 88 healthy smokers between 18-50 years, who have been smoking at least 10 cigarettes daily during at least one year preceding inclusion. Subjects and study personnel will be aware of which treatment is administered at a given visit.

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Tobacco Dependence


Nicotine, Nicorette® (Nicotine Gum)


Berzelius Clinical Research Center
SE-582 25




Johnson & Johnson Consumer & Personal Products Worldwide

Results (where available)

View Results


Published on BioPortfolio: 2014-08-27T03:14:05-0400

Clinical Trials [1094 Associated Clinical Trials listed on BioPortfolio]

Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product

A comparison of three products for oral nicotine replacement with respect to pharmacokinetics after single-dose of nicotine.

Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers.

This is a research study to verify the same effectiveness and safety profile for the test products, nicotine 2 mg gum and nicotine 4 mg gum, as for the already approved products, Nicorette...

Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum

This study examines the bioequivalence between an oral nicotine replacement product and Nicorette® gum.

Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® Gum

Single-dose pharmacokinetics with a new oral nicotine replacement product and Nicorette® gum.

Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® Gum

Single-dose pharmacokinetics with two new oral nicotine replacement products and Nicorette® gum.

PubMed Articles [2349 Associated PubMed Articles listed on BioPortfolio]

The Effects of Nicotine and Tobacco use on Brain Reward Function: Interaction with Nicotine Dependence Severity.

This study investigated the effects of nicotine/tobacco on neural activation during performance of a monetary incentivized delay task.

Multimodal Neuroimaging Differences in Nicotine Abstinent vs. Satiated Smokers.

Research on cigarette smokers suggests cognitive and behavioral impairments. However, much remains unclear how the functional neurobiology of smokers is influenced by nicotine state. Therefore, we sou...

Reinforcement Enhancing Effects of Nicotine via Patch and Nasal Spray.

Confirming preclinical findings, nicotine in humans (via smoking) enhances reinforcement from non-drug rewards. Recent demonstration of similar effects with nicotine via e-cigarettes suggests they may...

Nicotine Reduction Strategy: State of the science and challenges to tobacco control policy and FDA tobacco product regulation.

Nicotine addiction is the proximate cause of disease and death from cigarette smoking. In 1994, we proposed reducing the nicotine content of cigarettes to non-addicting levels to reduce the risk of yo...

Pregnancy-Induced Increases in the Nicotine Metabolite Ratio: Examining Changes During Antepartum and Postpartum.

Pregnancy-induced increases in nicotine metabolism may contribute to difficulties in quitting smoking during pregnancy. However, the time-course of changes in nicotine metabolism during early and late...

Medical and Biotech [MESH] Definitions

Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.

SMOKING of non-TOBACCO (or NICOTINE-containing) substances.

A plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; its dried leaves are used for SMOKING.

Chewing gum which contains NICOTINE.


More From BioPortfolio on "Bioequivalence Between Nicotine Replacement Products and Nicorette® Gum"

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Searches Linking to this Trial